The 2016 Morgan Stanley Global Healthcare Conference
Logotype for CVS Health Corporation

CVS Health (CVS) The 2016 Morgan Stanley Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

The 2016 Morgan Stanley Global Healthcare Conference summary

4 Nov, 2026

PBM value and drug cost management

  • 2016 YTD drug trend ran at 3.5% YoY, versus drug price inflation above 9%; formulary strategies were projected to save clients more than $9B from 2012 through 2017.

  • Most negotiated manufacturer rebates went to clients; contracts specified compensation, and clients had transparency and audit rights.

  • PBM tools included lower-cost generic plan designs, formulary negotiation, prior authorization and utilization management; 2016–17 selling interest centered on specialty cost controls and formulary management.

  • Management advocated faster FDA generic approvals and biosimilar launches to increase competition and help lower drug costs.

Competitive position and business wins

  • The 2016–17 selling season had $7.4B in gross wins, $4.6B in net business and 97.5% retention, as reported on the August earnings call.

  • Gross new business wins exceeded $30B over the prior three years; management cited a growing market as more people gained coverage and plans outsourced pharmacy benefits.

  • Consumer-facing assets included 9,600 pharmacies, MinuteClinics, specialty and infusion services, and long-term care capabilities; the Health Engagement Engine linked services to support adherence and care coordination.

  • Maintenance Choice, Pharmacy Advisor and Specialty Connect were cited as differentiated offerings supporting adherence, affordability and continuity of care.

Health plan growth and integration

  • More than 70 health plans used pharmacy benefit services; excluding Medicare, health plans represented about 60% of revenue, versus a roughly 50/50 mix a few years earlier.

  • Management cited Medicaid expansion in about 30 states, further potential in Texas and Florida, and Medicare growth from 10,000 people reaching age 65 each day for another 14–15 years.

  • NovoLogix integrated pharmacy and medical data to manage pharmacy spending billed through medical benefits and reduce costs; health plan clients worked with the service to apply the technology.

  • Of serviced Medicare Part D health plans, 73% had four-star-or-higher performance, up from 53% the prior year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CVS Health